StockData
VolitionRx Ltd logo

VolitionRx Ltd (VNRX) stock

VNRXNYSEIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 4/30
$0.18−0.01 (-3.02%)

Close on Nov 18, 2026Market cap $2.50MP/E –Yield –

VolitionRx revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

VolitionRx's revenue for the twelve months ending Jun 30, 2026 was $2.46M, up 86.3% year over year. For fiscal 2025 it was $1.73M, up 40.0% from the year before. The highest annual figure on record is $1.73M in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.73M+40.0%
FY2024Dec 31, 2024$1.23M+59.1%
FY2023Dec 31, 2023$775.30K+153.0%
FY2022Dec 31, 2022$306.39K+240.3%
FY2021Dec 31, 2021$90.04K+570.3%
FY2020Dec 31, 2020$13.43K-21.4%
FY2019Dec 31, 2019$17.10K+15.6%
FY2014Dec 31, 2014$14.79K-73.1%
FY2012Dec 31, 2012$54.97K–
FY2011Dec 31, 2011$0–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$398.66K-2.0%
Q1 FY2026Mar 31, 2026$985.08K+299.8%
Q4 FY2025Dec 31, 2025$447.03K+133.2%
Q3 FY2025Sep 30, 2025$627.28K+32.2%
Q2 FY2025Jun 30, 2025$406.69K+2.8%
Q1 FY2025Mar 31, 2025$246.39K+43.6%
Q4 FY2024Dec 31, 2024$191.66K-21.4%
Q3 FY2024Sep 30, 2024$474.52K+187.2%
Q2 FY2024Jun 30, 2024$395.80K+83.0%
Q1 FY2024Mar 31, 2024$171.54K+14.5%
Q4 FY2023Dec 31, 2023$243.97K+103.8%
Q3 FY2023Sep 30, 2023$165.21K+405.0%
Q2 FY2023Jun 30, 2023$216.31K+444.1%
Q1 FY2023Mar 31, 2023$149.81K+31.2%
Q4 FY2022Dec 31, 2022$119.72K+740.7%
Q3 FY2022Sep 30, 2022$32.71K+28.4%
Q2 FY2022Jun 30, 2022$39.75K+60.4%
Q1 FY2022Mar 31, 2022$114.21K+347.4%
Q4 FY2021Dec 31, 2021$14.24K+100.0%
Q3 FY2021Sep 30, 2021$25.48K+4331.8%
Q2 FY2021Jun 30, 2021$24.78K+377.1%
Q1 FY2021Mar 31, 2021$25.53K+4593.0%
Q4 FY2020Dec 31, 2020$7.12K–
Q3 FY2020Sep 30, 2020$575-96.6%
Q2 FY2020Jun 30, 2020$5.19K–
Q1 FY2020Mar 31, 2020$544–
Q4 FY2019Dec 31, 2019$0–
Q3 FY2019Sep 30, 2019$17.10K–
Q2 FY2019Jun 30, 2019$0–

More VolitionRx figures

See a number that looks wrong?